Canopy Growth Corporation (NASDAQ:CGC) shares continued to move higher Tuesday after gaining more than 9% in Monday's session. Here's a look at what you need to know.
What To Know: Canopy Growth stock popped Monday around the same time former President Donald Trump selected Sen. J.D. Vance (R-Ohio) as his vice-presidential running-mate. Ohio legalized adult-use cannabis in November 2023.
According to a Marijuana Moment report, Vance believes states should set their own cannabis laws. He's also suggested that he's against incarcerating individuals for low-level possession.
Vance voted against the Secure and Fair Enforcement Regulation (SAFER) Banking Act when it was approved in September 2023, noting that "the bill was crafted in such a way that actually would have opened up access to banking resources for fentanyl traffickers and others." However, Vance left the door open to approving a revised bill in the future.
"If the legislation is better, I'd be more likely to support it," he said at the time.
What Else: The Czech government is reportedly pursuing a full commercial adult-use cannabis market as part of its Cannabis Management Act, according to a report released Monday from Business of Cannabis. Canopy Growth currently serves the medical marijuana market in the Czech Republic.
Canopy Growth still faces several headwinds, including the uncertain regulatory environment in the U.S., and the company has yet to become profitable. According to data from Benzinga Pro, Canopy Growth shares are trading below the stock's 50-day moving average of $8.02. It's also worth noting that approximately 17.5% of Canopy's float is currently being sold short.
Will CGC Stock Go Up?
When trying to assess whether or not Canopy Growth will trade higher from current levels, it's a good idea to take a look at analyst forecasts.
Wall Street analysts have an average 12-month price target of $2 on Canopy Growth. One analyst has a negative rating on Canopy Growth's stock.
In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Canopy Growth have performed in recent history.
Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Canopy Growth is 80.49% up year-to-date. The average analyst price target suggests the stock could have further downside ahead.
For a broad overview of everything you need to know about Canopy Growth, visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.
CGC Price Action: According to Benzinga Pro, Canopy Growth shares ended Tuesday session 3.08% higher at $7.36.
Canopy Growth Corporation（納斯達克股票代碼：CGC）股價在週一的交易中上漲了9％以上，週二繼續走高。以下是你需要知道的內容。
須知：週一，Canopy Growth股票暴漲，大約在前總統唐納德·特朗普選擇參議員萬斯（俄亥俄州）作爲副總統競選夥伴的同時。俄亥俄州於 2023 年 11 月將成人使用的大麻合法化。
根據大麻時刻的一份報告，萬斯認爲各州應該制定自己的大麻法。他還表示，他反對以低等級持有財產爲由監禁個人。
萬斯在2023年9月批准《安全和公平執法條例（SAFER）銀行法》時對該法案投了反對票，並指出 “該法案的起草方式實際上將爲芬太尼販運者和其他人打開獲得銀行資源的渠道。”但是，萬斯爲將來批准修訂後的法案敞開了大門。
他當時說：“如果立法更好，我更有可能支持它。”
還有什麼：根據大麻商業週一發佈的一份報告，據報道，作爲其《大麻管理法》的一部分，捷克政府正在尋求一個全面的商業成人用大麻市場。Canopy Growth目前爲捷克共和國的醫用大麻市場提供服務。
Canopy Growth仍然面臨一些不利因素，包括美國不確定的監管環境，該公司尚未盈利。根據Benzinga Pro的數據，Canopy Growth股票的交易價格低於該股的50天移動平均線8.02美元。還值得注意的是，Canopy目前約有17.5％的股票被賣空。
CGC股票會上漲嗎？
在嘗試評估Canopy Growth的交易價格是否會從當前水平上漲時，最好看一下分析師的預測。
華爾街分析師將Canopy Growth的平均12個月目標股價定爲2美元。一位分析師對Canopy Growth的股票給予負面評級。
上個月，一位分析師調整了目標股價。以下是最近的目標股價變化 [分析師評級]。本辛加還追蹤華爾街最準確的分析師。看看報道Canopy Growth的分析師在近代歷史上的表現。
股票不會沿直線移動。平均股市回報率約爲每年10％。今年迄今爲止，冠層增長率增長了80.49％。分析師的平均目標股價表明，該股未來可能會進一步下跌。
要全面了解您需要了解的有關Canopy Growth的所有信息，請訪問此處。如果你想超越自我，沒有比 Benzinga Pro 更好的工具可以幫助你做到這一點。立即開始免費試用。
CGC價格走勢：根據Benzinga Pro的數據，Canopy Growth股價週二收盤上漲3.08％，至7.36美元。
